Detalhe da pesquisa
1.
Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate.
Angew Chem Int Ed Engl
; 58(5): 1437-1441, 2019 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537284
2.
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes.
Pharmaceutics
; 13(1)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467652
3.
Hyaluronic acid conjugates for topical treatment of skin cancer lesions.
Sci Adv
; 7(24)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117055
4.
Design principles of drug combinations for chemotherapy.
J Control Release
; 323: 36-46, 2020 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32283210
5.
Cellular backpacks for macrophage immunotherapy.
Sci Adv
; 6(18): eaaz6579, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494680
6.
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
J Control Release
; 305: 130-154, 2019 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004668
7.
Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin.
Bioeng Transl Med
; 4(2): e10129, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249879
8.
Click-Particle Display for Base-Modified Aptamer Discovery.
ACS Chem Biol
; 14(12): 2652-2662, 2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31532184
9.
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.
Bioeng Transl Med
; 3(1): 49-57, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29376133
10.
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer.
J Control Release
; 267: 191-202, 2017 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823957
11.
Engineering live cell surfaces with functional polymers via cytocompatible controlled radical polymerization.
Nat Chem
; 9(6): 537-545, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28537595
12.
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.
J Control Release
; 229: 154-162, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27034194